RaySearch Laboratories AB (publ)
STO:RAY B

Watchlist Manager
RaySearch Laboratories AB (publ) Logo
RaySearch Laboratories AB (publ)
STO:RAY B
Watchlist
Price: 204.5 SEK 0.25%
Market Cap: 7B SEK
Have any thoughts about
RaySearch Laboratories AB (publ)?
Write Note

RaySearch Laboratories AB (publ)
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RaySearch Laboratories AB (publ)
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
RaySearch Laboratories AB (publ)
STO:RAY B
Capital Expenditures
-kr209.3m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Capital Expenditures
kr5.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mentice AB
STO:MNTC
Capital Expenditures
-kr7m
CAGR 3-Years
35%
CAGR 5-Years
11%
CAGR 10-Years
N/A
O
Ortivus AB
STO:ORTI B
Capital Expenditures
-kr10.8m
CAGR 3-Years
-58%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Capital Expenditures
-kr250.7m
CAGR 3-Years
-55%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Capital Expenditures
-kr10.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

RaySearch Laboratories AB (publ)
Glance View

Market Cap
7B SEK
Industry
Health Care

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

RAY B Intrinsic Value
219.97 SEK
Undervaluation 7%
Intrinsic Value
Price

See Also

What is RaySearch Laboratories AB (publ)'s Capital Expenditures?
Capital Expenditures
-209.3m SEK

Based on the financial report for Dec 31, 2023, RaySearch Laboratories AB (publ)'s Capital Expenditures amounts to -209.3m SEK.

What is RaySearch Laboratories AB (publ)'s Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
1%

Over the last year, the Capital Expenditures growth was -4%. The average annual Capital Expenditures growth rates for RaySearch Laboratories AB (publ) have been 2% over the past three years , 1% over the past five years .

Back to Top